Cargando…

Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome

BACKGROUND: Anti-EGFR monoclonal antibodies have shown efficacy in the treatment of metastatic colorectal cancer (mCRC). One of the mechanism is the antibody-dependent cell-mediated cytotoxicity (ADCC) in which Fc region of the antibody binds to the Fc gamma receptors (FcγR) expressed by immune cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calemma, Rosa, Ottaiano, Alessandro, Trotta, Anna Maria, Nasti, Guglielmo, Romano, Carmela, Napolitano, Maria, Galati, Domenico, Borrelli, Pasquale, Zanotta, Serena, Cassata, Antonino, Castello, Giuseppe, Iaffaioli, Vincenzo Rosario, Scala, Stefania
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551834/ https://www.ncbi.nlm.nih.gov/pubmed/23171437 http://dx.doi.org/10.1186/1479-5876-10-232

Ejemplares similares

Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition
por: Ottaiano, Alessandro, et al.
Publicado: (2013)

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2018)

Study of Ras Mutations’ Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2020)

Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment
por: Barbieri, Antonio, et al.
Publicado: (2017)

Prognostic Significance of CXCR4 in Colorectal Cancer: An Updated Meta-Analysis and Critical Appraisal
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice
por: Ottaiano, Alessandro, et al.
Publicado: (2019)

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors
por: Ottaiano, Alessandro, et al.
Publicado: (2018)

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol
por: Ottaiano, Alessandro, et al.
Publicado: (2019)

A New Source of Heterogeneity in Comparative and Translational Clinical Trials: The “Border-Time” Bias
por: Santorsola, Mariachiara, et al.
Publicado: (2022)

First line targeted therapies in breast cancer: focus on bevacizumab
por: Milano, Amalia, et al.
Publicado: (2007)

Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column
por: Kiyoshi, Masato, et al.
Publicado: (2018)

New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
por: D’Alterio, Crescenzo, et al.
Publicado: (2020)

Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa
por: Sakae, Yoshitake, et al.
Publicado: (2017)

Characterization of KRAS Mutational Regression in Oligometastatic Patients
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics
por: Granata, Vincenza, et al.
Publicado: (2023)

Correction: Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics
por: Granata, Vincenza, et al.
Publicado: (2023)

FcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer
por: Wang, De-shen, et al.
Publicado: (2017)

Fc‐gamma IIIa‐V158F receptor polymorphism contributes to the severity of Guillain‐Barré syndrome
por: Hayat, Shoma, et al.
Publicado: (2020)

The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIa
por: Yamaguchi, Yuki, et al.
Publicado: (2022)

FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia
por: Norris, Peter A. A., et al.
Publicado: (2020)

Natural killer cells activity in a metastatic colorectal cancer patient with complete and long lasting response to therapy
por: Ottaiano, Alessandro, et al.
Publicado: (2017)

Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?
por: Ottaiano, Alessandro, et al.
Publicado: (2018)

The antibody-binding Fc gamma receptor IIIa / CD16a is N-glycosylated with high occupancy at all five sites
por: Lampros, Elizabeth A., et al.
Publicado: (2022)

Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2020)

Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease?
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Etanercept induces remission of polyarteritis nodosa: a case report
por: Capuozzo, Maurizio, et al.
Publicado: (2014)

Fc γ receptor IIIa/CD16a processing correlates with the expression of glycan-related genes in human natural killer cells
por: Patel, Kashyap R., et al.
Publicado: (2020)

Epidemiology and Economic Impact of Celiac Disease in the South Vesuvian Area of Naples: A Survey
por: Capuozzo, Maurizio, et al.
Publicado: (2013)

Association of Fc gamma-receptors IIa, IIIa, and IIIb genetic polymorphism with susceptibility to chronic periodontitis in South Indian population
por: Hans, Veenu Madaan, et al.
Publicado: (2015)

Dendritic Cell and Cancer Therapy
por: Galati, Domenico, et al.
Publicado: (2023)

Neoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial
por: Nasti, G, et al.
Publicado: (2013)

Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization
por: Capuozzo, Maurizio, et al.
Publicado: (2013)

Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: A systematic review
por: Patrone, Renato, et al.
Publicado: (2021)

A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report
por: De Divitiis, Chiara, et al.
Publicado: (2015)

Can the addition of radiotherapy postoperatively increase clinical outcome of patients with gastric cancer? A systematic review of the literature and meta-analysis
por: Fiorica, Francesco, et al.
Publicado: (2017)

Ionic liquids IIIA
por: Rogers, Robin D, et al.
Publicado: (2005)

Magnetic Resonance Features of Liver Mucinous Colorectal Metastases: What the Radiologist Should Know
por: Granata, Vincenza, et al.
Publicado: (2022)

Binding affinities of human IgG1 and chimerized pig and rabbit derivatives to human, pig and rabbit Fc gamma receptor IIIA
por: Bhatti, Maryam M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_htehe5srpok5bmkgimb6i4f9l6